Dow Jones

43,494.68

0.20%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

EYEN

Eyenovia (EYEN)

Eyenovia Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EYEN

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
20/11/2024	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EYEN	Eyenovia Inc
13/11/2024	05:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EYEN	Eyenovia Inc
12/11/2024	16:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EYEN	Eyenovia Inc
08/10/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EYEN	Eyenovia Inc
01/10/2024	16:12	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:EYEN	Eyenovia Inc
30/09/2024	05:24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EYEN	Eyenovia Inc
03/09/2024	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EYEN	Eyenovia Inc
03/09/2024	07:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:EYEN	Eyenovia Inc
07/08/2024	07:00	PR Newswire (US)	Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States	NASDAQ:EYEN	Eyenovia Inc
18/07/2024	18:46	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:EYEN	Eyenovia Inc
06/05/2024	15:01	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:EYEN	Eyenovia Inc
18/03/2024	06:12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:EYEN	Eyenovia Inc
31/01/2024	07:13	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:EYEN	Eyenovia Inc
21/09/2023	07:00	GlobeNewswire Inc.	Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference	NASDAQ:EYEN	Eyenovia Inc
29/06/2023	17:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:EYEN	Eyenovia Inc
27/06/2023	15:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EYEN	Eyenovia Inc
12/05/2023	08:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EYEN	Eyenovia Inc
11/05/2023	05:02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:EYEN	Eyenovia Inc
11/05/2023	05:02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:EYEN	Eyenovia Inc
27/04/2023	15:28	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:EYEN	Eyenovia Inc
13/02/2023	15:07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:EYEN	Eyenovia Inc
04/01/2023	15:07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:EYEN	Eyenovia Inc
23/12/2022	15:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:EYEN	Eyenovia Inc
23/12/2022	05:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:EYEN	Eyenovia Inc
11/11/2022	05:25	TipRanks	H.C. Wainwright Sticks to Its Buy Rating for Eyenovia (EYEN)	NASDAQ:EYEN	Eyenovia Inc
05/10/2022	05:30	TipRanks	Analysts Offer Insights on Healthcare Companies: Applied Genetic Technologies (AGTC), Eyenovia (EYEN) and ATAI Life Sciences (ATAI)	NASDAQ:EYEN	Eyenovia Inc
12/08/2022	15:03	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:EYEN	Eyenovia Inc
29/06/2022	08:11	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:EYEN	Eyenovia Inc
30/03/2022	13:44	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EYEN	Eyenovia Inc
09/03/2022	07:42	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:EYEN	Eyenovia Inc